KAT5 and hepatocellular carcinoma: In the present study, hepatoma cells treated with the TIP60 inhibitor TH1834 or transfected with the TWIST1 AC2 mutant showed loss of acetylation and nuclear localization of both TWIST1 and SPZ1.